Concomitant Febuxostat Enhances Methotrexate-Induced Hepatotoxicity by Inhibiting Breast Cancer Resistance Protein

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-56900-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Methotrexate Hepatotoxicity in Psoriasis.

BMJ
1972English

Cytoprotective Effects of Molsidomine Against Methotrexate-Induced Hepatotoxicity: An Experimental Rat Study

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Histologic Aspects of Concomitant Resistance Induced by Nonimmunogenic Murine Tumors2

Journal of the National Cancer Institute
Cancer ResearchOncology
1986English

MMP1 Expression Is Activated by Slug and Enhances Multi-Drug Resistance (MDR) in Breast Cancer

PLoS ONE
Multidisciplinary
2017English

Inhibiting PAD2 Enhances the Anti-Tumor Effect of Docetaxel in Tamoxifen-Resistant Breast Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2020English

Low-Dose Methotrexate Enhances Cycling of Highly Anaplastic Cancer Cells

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Inhibiting the mTOR Pathway Synergistically Enhances Cytotoxicity in Ovarian Cancer Cells Induced by Etoposide Through Upregulation of C-Jun

Clinical Cancer Research
Cancer ResearchOncology
2011English

Hypoxia-Induced miR-210 in Epithelial Ovarian Cancer Enhances Cancer Cell Viability via Promoting Proliferation and Inhibiting Apoptosis

International Journal of Oncology
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy